🔗 Permalink

Inventor profile of:

Cheng CHEN

City:

Hefei, Anhui

Country:

China

Published Applications:

Last publication date:

2025-04-24

Top Assignees for applications by Cheng CHEN

The entities that hold a legal rights for patent applications filed by inventor CHEN Cheng:

PRECEDO PHARMACEUTICALS CO., LTD 8 Hefei, Anhui, China
HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES 3 Hefei, Anhui, China
HEFEI GRACEVO BIO-MEDICINE CO., LTD 1 Hefei, Anhui, China
HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES 1 Hefei, Anhui, United States
Tarapeutics Science Inc. 1 Bengbu City, Anhui Province, China
Tarapeutics Science Inc. 1 Bengbu, Anhui, China
TARAPEUTICS SCIENCE INC. 1 Bengbu City, Anhui, China
PRECEDO PHARMACEUTICALS CO., LTD 1 Hefei, Anhui Province, China
Hefei Institutes of Physical Science, Chinese Academy of Sciences 1 Anhui, China
PRECEDO PHARMACEUTICALS CO., LTD 1 Hefei, Annui, China
PRECEDO PHARMACEUTICALS CO., LTD 1 Anhui, China
TARAPEUTICS SCIENCE INC. 1 Anhui, China
Tarapeutics Science Inc. 1 Bengbu, China
HEFEI COSOURCE PHARMACEUTICAL CO., LTD. 1 Hefei, Anhui, China

Recent patent applications by CHEN Cheng

Cheng CHEN from Hefei, Anhui, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-24

US20250129329A1

Chemistry; metallurgy

CULTURE MEDIUM FOR HEPATOMA ORGANOID CULTURE, HEPATOMA ORGANOID CULTURE METHOD, AND APPLICATION THEREOF

#2 | 2025-03-27

US20250101378A1

Chemistry; metallurgy

CULTURE MEDIUM AND CULTURE METHOD FOR MAMMARY EPITHELIAL CELLS, AND USE OF MAMMARY EPITHELIAL CELLS

#3 | 2024-12-19

US20240418703A1

Physics

CULTURE MEDIUM FOR PRIMARY OVARIAN CANCER CELLS, CULTURE METHOD AND APPLICATION THEREOF

#4 | 2024-11-28

US20240392251A1

Chemistry; metallurgy

CULTURE MEDIUM AND CULTURE METHOD FOR LUNG CANCER EPITHELIAL CELLS, AND APPLICATION THEREOF

#5 | 2024-10-17

US20240344035A1

Chemistry; metallurgy

Culture Medium and Culture Method for Human Primary Acute Myeloid Leukemia Cells

#6 | 2024-10-17

US20240344020A1

Chemistry; metallurgy

CULTURE MEDIUM FOR LUNG CANCER EPITHELIAL CELLS, CULTURE METHOD, AND APPLICATION THEREOF

#7 | 2024-09-26

US20240319170A1

Physics

CULTURE MEDIUM AND CULTURE METHOD FOR PRIMARY CELLS OF INTESTINAL CANCER

#8 | 2023-07-27

US20230235283A1

Chemistry; metallurgy

CULTURE MEDIUM FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA EPITHELIAL CELLS, CULTURE METHOD, AND APPLICATION THEREOF

#9 | 2023-03-23

US20230091960A1

Chemistry; metallurgy

CULTURE MEDIUM FOR PRIMARY CELLS OF ESOPHAGEAL SQUAMOUS CARCINOMA, AND CULTIVATION METHOD THEREFOR

#10 | 2022-09-15

US20220288064A1

Human necessities

PYRAZOLE DERIVATIVES AND USE THEREOF

#11 | 2022-05-12

US20220143001A1

Human necessities

Pan-RAF kinase inhibitor and use thereof

#12 | 2022-03-03

US20220064117A1

Chemistry; metallurgy

PAN-KIT KINASE INHIBITOR HAVING QUINOLINE STRUCTURE AND APPLICATION THEREOF

#13 | 2022-01-06

US20220002287A1

Chemistry; metallurgy

Indazole kinase inhibitor and use thereof

#14 | 2020-10-15

US20200323850A1

Human necessities

Pyrimidine derivative kinase inhibitors

#15 | 2020-01-09

US20200010471A1

Chemistry; metallurgy

Inhibitor of FLT3 kinase and use thereof

#16 | 2019-03-21

US20190084960A1

Chemistry; metallurgy

Selective C-KIT kinase inhibitor

#17 | 2019-02-07

US20190040013A1

Chemistry; metallurgy

Irreversible bruton's tyrosine kinase inhibitor

#18 | 2019-01-10

US20190010159A1

Chemistry; metallurgy

Kinase inhibitor against wild-type and mutant EGFR

#19 | 2018-02-01

US20180030054A1

Chemistry; metallurgy

Inhibitor of FLT3 kinase and use thereof

InventorID:

2104232 ⎘